VEGFA and coronary artery disorder: VEGFA is among the top 64 novel CAD loci increasing risk of CAD (OR 1.95 (95% C.I. 1.03–1.06), p = 1.9 × 10−12) (20) and waist to hip ratio adjusted BMI p = 3 × 10−27 (62).